Drugs and Devices

Study: Phase II drugs may help prevent migraine attacks

Two studies presented at the American Academy of Neurology’s 66th Annual Meeting, 2014, may offer hope to people with migraines. The two phase II drugs (ALD403 and LY2951742) significantly reduced the number of migraine days per month. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares